Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.

about

Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.

Item

http://www.wikidata.org/entity/Q50331886

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Complete response in a patient ...... plus systemic nab-paclitaxel.

@en

Complete response in a patient ...... plus systemic nab-paclitaxel.

@nl

type

Item

label

Complete response in a patient ...... plus systemic nab-paclitaxel.

@en

Complete response in a patient ...... plus systemic nab-paclitaxel.

@nl

prefLabel

Complete response in a patient ...... plus systemic nab-paclitaxel.

@en

Complete response in a patient ...... plus systemic nab-paclitaxel.

@nl

P1476

Complete response in a patient ...... y plus systemic nab-paclitaxel

@en

P2093

Cosmo Damiano Gadaleta

http://www.w3.org/2001/XMLSchema#string

Francesco Giotta

http://www.w3.org/2001/XMLSchema#string

Gennaro Palmiotti

http://www.w3.org/2001/XMLSchema#string

Girolamo Ranieri

http://www.w3.org/2001/XMLSchema#string

Giuseppe Laricchia

http://www.w3.org/2001/XMLSchema#string

Ilaria Marech

http://www.w3.org/2001/XMLSchema#string

Mariangela Porcelli

http://www.w3.org/2001/XMLSchema#string

Vito Fazio

http://www.w3.org/2001/XMLSchema#string

P2860

A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement.

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Hepatic-arterial chemotherapy.

The blood supply of neoplasms in the liver.

Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma

Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer.

Hepatic arterial infusion chemotherapy for liver metastases from breast cancer.

Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity.

P304

8197-8203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.18632/ONCOTARGET.23793

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29487726

http://www.w3.org/2001/XMLSchema#string

P932

5814293

http://www.w3.org/2001/XMLSchema#string